{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:40:38Z","timestamp":1791974438041,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>This study report clinical course, etiology, management, and long-term outcome of children who developed toxic epidermal necrolysis-like reaction (TEN-LR) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We retrospectively collected children with TEN-LR occurring after allo-HSCT performed in 2 pediatric bone marrow units between 2005 and 2014. We identified 6 cases of TEN-LR of 322 patients (1.8%). Possible triggers of TEN included antibiotics, antiepileptics, antimycotics, and <jats:italic toggle=\"yes\">Mycoplasma<\/jats:italic> infection. In 3 patients TEN-LR occurred concurrently with severe multiorgan acute graft versus host disease. The management of TEN included administration of high doses of intravenous immunoglobulins and steroids (n=6), anti-tumor necrosis factor (n=3), and plasmapheresis (n=3) and whenever possible, discontinuation of the potentially causative drugs. Four patients (66%) reached a complete clinical response of TEN-LR after a median of 11.2 days. Two children (34%) are presently alive, 1 with long-term ocular sequelae. TEN-LR is a potentially lethal complication that may occur after HSCT also in pediatric patients. In our experience, TEN-LR and acute graft versus host disease probably coexisted and an overlap between the 2 forms is suggested. The multidisciplinary approaches involving specialized nurses, hematologists, dermatologists, burn surgeons, and infectious disease specialists is crucial to treat these patients.<\/jats:p>","DOI":"10.1097\/mph.0000000000000820","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T15:08:08Z","timestamp":1488899288000},"page":"254-258","source":"Crossref","is-referenced-by-count":5,"title":["Toxic Epidermal Necrolysis-like Reaction After Hematopoietic Stem Cell Transplantation in Children"],"prefix":"10.1097","volume":"39","author":[{"given":"Maura","family":"Faraci","sequence":"first","affiliation":[{"name":"Paediatric Haematology-Oncology Department, Stem Cell Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giardino","sequence":"additional","affiliation":[{"name":"Paediatric Haematology-Oncology Department, Stem Cell Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Lanino","sequence":"additional","affiliation":[{"name":"Paediatric Haematology-Oncology Department, Stem Cell Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Morreale","sequence":"additional","affiliation":[{"name":"Paediatric Haematology-Oncology Department, Stem Cell Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Ghibaudo","sequence":"additional","affiliation":[{"name":"Paediatric Haematology-Oncology Department, Stem Cell Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Francesia Berta","sequence":"additional","affiliation":[{"name":"Paediatric Haematology-Oncology Department, Stem Cell Transplantation Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Risso","sequence":"additional","affiliation":[{"name":"Immuno-Haematology and Transfusion Medicine Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Castagnola","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimmo","family":"Ripaldi","sequence":"additional","affiliation":[{"name":"SCT Unit Santobono-Pausilipon Hospital, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Moscatelli","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Istituto G. Gaslini"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ghigliotti","sequence":"additional","affiliation":[{"name":"Dermatology Clinic, S Martino IST Hospital, Genova"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","first-page":"5","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"16","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"key":"R3-20230918","first-page":"762s","article-title":"Clinical aspects of streptococcal and staphylococcal toxinic diseases","volume":"4","author":"Floret","year":"2000","journal-title":"Arch Pediatr"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.2010-3322","article-title":"Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"128","author":"Finkelstein","year":"2011","journal-title":"Pediatrics"},{"key":"R6-20230918","first-page":"158","article-title":"Toxic epidermal necrolysis following bone marrow transplantation","volume":"34","author":"Friedman","year":"1984","journal-title":"Cutis"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/BCR.0000000000000040","article-title":"Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management","volume":"35","author":"Macedo","year":"2014","journal-title":"J Burn Care Res"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1346-8138.1997.tb02308.x","article-title":"Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"24","author":"Takeda","year":"1997","journal-title":"J Dermatol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0190-9622(90)70307-4","article-title":"Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases","volume":"23","author":"Villada","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.1016\/S0190-9622(03)00478-X","article-title":"Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug","volume":"49","author":"H\u00e4llgren","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/annonc\/mdj126","article-title":"Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy","volume":"17","author":"Curigliano","year":"2006","journal-title":"Ann Oncol"},{"key":"R13-20230918","first-page":"20","article-title":"Toxic epidermal necrolysis due to voriconazole: case report and review","volume":"16","author":"Gomulka","year":"2014","journal-title":"Dermatol Online J"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/INF.0b013e3182566311","article-title":"Voriconazole-induced phototoxicity in children","volume":"31","author":"Bernhard","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/pbc.24897","article-title":"Phototoxic dermatoses in pediatric BMT patients receiving voriconazole","volume":"61","author":"Goyal","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R16-20230918","first-page":"5","article-title":"Safety of lamotrigine in paediatrics: a systematic review","volume":"12","author":"Egunsola","year":"2015","journal-title":"BMJ Open"},{"key":"R17-20230918","first-page":"202","article-title":"Toxic epidermal necrolysis induced by phenobarbital in a Rwandan child: report of a case","volume":"17","author":"Kaputu-Kalala-Malu","year":"2014","journal-title":"Pan Afr Med J"},{"key":"R18-20230918","first-page":"379","article-title":"Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia","volume":"105","author":"Gamba","year":"2014","journal-title":"Recenti Prog Med"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bmt.1703624","article-title":"Toxic epidermal necrolysis: differential diagnosis of an epidermolytic dermopathy in a hematopoietic stem cell transplant recipient","volume":"30","author":"Zakrzewski","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bmt.1705572","article-title":"Toxic epidermal necrolysis after allogeneic haematopoietic stem cell transplantation","volume":"39","author":"Hilgendorf","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2133.1976.tb00824.x","article-title":"Erythema multiforme in children. Response to treatment with systemic corticosteroids","volume":"95","author":"Rasmussen","year":"1976","journal-title":"Br J Dermatol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-0214","article-title":"Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"87","author":"Kardaun","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s004310050561","article-title":"Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children","volume":"156","author":"Kakourou","year":"1997","journal-title":"Eur J Pediatr"},{"key":"R24-20230918","first-page":"679","article-title":"Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality","volume":"12","author":"Aires","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":"Antitumour necrosis factor-a antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1346-8138.2009.00616.x","article-title":"Toxic epidermal necrolysis successfully treated with etanercept","volume":"36","author":"Gubinelli","year":"2009","journal-title":"J Dermatol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000372-200010000-00005","article-title":"Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis","volume":"22","author":"Paquet","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-4362.1997.00192.x","article-title":"Plasmapheresis in toxic epidermal necrolysis","volume":"36","author":"Chaidemenos","year":"1997","journal-title":"Int J Dermatol"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","article-title":"Plasma exchange in patients with toxic epidermal necrolysis","volume":"6","author":"Bamichas","year":"2002","journal-title":"Ther Apher"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201705000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:34:18Z","timestamp":1695011658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201705000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000820","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}